tradingkey.logo

Akso Health Group

AHG
1.390USD
-0.020-1.42%
Close 12/26, 16:00ETQuotes delayed by 15 min
767.09MMarket Cap
LossP/E TTM

Akso Health Group

1.390
-0.020-1.42%

More Details of Akso Health Group Company

Akso Health Group, formerly Xiaobai Maimai Inc, is a China-based company mainly engaged in e-commerce business. The Company provides services through the Xiaobai Maimai application (APP), a one-stop e-commerce platform. The Company provides products covering food and beverage, wine, cosmetic products, fashion and apparel, entertainment, houseware, home appliances and others. The Company is also engaged in social e-commerce platform business, cancer therapy and radiotherapy oncology service provider business, and the sale of coronavirus disease 2019 (COVID-19) Rapid Antigen Tests.

Akso Health Group Info

Ticker SymbolAHG
Company nameAkso Health Group
IPO dateNov 03, 2017
CEOAn (Xiaobo)
Number of employees27
Security typeDepository Receipt
Fiscal year-endNov 03
AddressRm 8201-4-4(A) 2Nd Floor Qiantongyua Bld, No. 44 Moscow Rd Qianwan Bonded Port Are, Qingdao Pilot Free Trade Zone
CityQINGDAO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryChina
Postal code- -
Phone
Websitehttps://www.ahgtop.com/en/index.html
Ticker SymbolAHG
IPO dateNov 03, 2017
CEOAn (Xiaobo)

Company Executives of Akso Health Group

Name
Name/Position
Position
Shareholding
Change
Mr. Stephen (Steven) Markscheid
Mr. Stephen (Steven) Markscheid
Independent Director
Independent Director
--
--
Mr. Dagang Guo
Mr. Dagang Guo
Independent Director
Independent Director
--
--
Mr. David Wei Tang
Mr. David Wei Tang
Independent Director
Independent Director
--
--
Mr. Xiaobo An
Mr. Xiaobo An
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Rui (Kerrie) Zhang
Ms. Rui (Kerrie) Zhang
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Wenjuan (Vivian) Liu
Ms. Wenjuan (Vivian) Liu
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Stephen (Steven) Markscheid
Mr. Stephen (Steven) Markscheid
Independent Director
Independent Director
--
--
Mr. Dagang Guo
Mr. Dagang Guo
Independent Director
Independent Director
--
--
Mr. David Wei Tang
Mr. David Wei Tang
Independent Director
Independent Director
--
--
Mr. Xiaobo An
Mr. Xiaobo An
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Rui (Kerrie) Zhang
Ms. Rui (Kerrie) Zhang
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Wenjuan (Vivian) Liu
Ms. Wenjuan (Vivian) Liu
Director
Director
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Marketing promotion service revenue
14.37M
97.22%
Sale of medical devices
415.02K
2.81%
Tax and surcharges
-3.82K
-0.03%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Marketing promotion service revenue
14.37M
97.22%
Sale of medical devices
415.02K
2.81%
Tax and surcharges
-3.82K
-0.03%

Shareholding Stats

Updated: Sun, Feb 23
Updated: Sun, Feb 23
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Renaissance Technologies LLC
0.02%
Other
99.98%
Shareholders
Shareholders
Proportion
Renaissance Technologies LLC
0.02%
Other
99.98%
Shareholder Types
Shareholders
Proportion
Hedge Fund
0.02%
Other
99.98%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
10
157.24K
0.04%
--
2025Q3
12
157.24K
0.05%
-16.31K
2025Q2
14
173.55K
0.05%
-35.73K
2025Q1
14
209.28K
0.05%
-77.89K
2024Q4
14
234.20K
0.10%
+32.28K
2024Q3
15
201.92K
0.15%
-43.98K
2024Q2
15
245.90K
0.25%
-29.38K
2024Q1
15
275.29K
0.24%
-76.12K
2023Q4
17
276.30K
1.00%
-51.82K
2023Q3
17
328.12K
1.87%
-33.76K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Renaissance Technologies LLC
130.80K
0.02%
-14.40K
-9.92%
Jun 30, 2025
Geode Capital Management, L.L.C.
14.97K
0%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
12.96K
0%
+5.32K
+69.62%
Jun 30, 2025
Catalina Capital Group, LLC
--
0%
-31.94K
-100.00%
Mar 31, 2025
Millennium Management LLC
--
0%
-22.83K
-100.00%
Jun 30, 2025
Rhumbline Advisers Ltd. Partnership
4.54K
0%
-490.00
-9.74%
Jun 30, 2025
Geowealth Management LLC
--
0%
-1.33K
-100.00%
Jun 30, 2025
Aperio Group, LLC
--
0%
-1.33K
-100.00%
Jun 30, 2025
Two Sigma Investments, LP
10.28K
0%
-670.00
-6.12%
Jun 30, 2025
XTX Markets LLC
--
0%
-11.79K
-100.00%
Jun 30, 2024

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
Aug 10, 2020
Merger
3→1
Aug 10, 2020
Merger
3→1
Aug 10, 2020
Merger
3→1
Aug 10, 2020
Merger
3→1
Date
Type
Ratio
Aug 10, 2020
Merger
3→1
Aug 10, 2020
Merger
3→1
Aug 10, 2020
Merger
3→1
Aug 10, 2020
Merger
3→1

FAQs

Who are the top five shareholders of Akso Health Group?

The top five shareholders of Akso Health Group are:
Renaissance Technologies LLC holds 130.80K shares, accounting for 0.02% of the total shares.
Geode Capital Management, L.L.C. holds 14.97K shares, accounting for 0.00% of the total shares.
UBS Financial Services, Inc. holds 12.96K shares, accounting for 0.00% of the total shares.
Catalina Capital Group, LLC holds 0.00 shares, accounting for 0.00% of the total shares.
Millennium Management LLC holds 0.00 shares, accounting for 0.00% of the total shares.

What are the top three shareholder types of Akso Health Group?

The top three shareholder types of Akso Health Group are:
Renaissance Technologies LLC
Other

How many institutions hold shares of Akso Health Group (AHG)?

As of 2025Q4, 10 institutions hold shares of Akso Health Group, with a combined market value of approximately 157.24K, accounting for 0.04% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.00%.

What is the biggest source of revenue for Akso Health Group?

In FY2025, the Marketing promotion service revenue business generated the highest revenue for Akso Health Group, amounting to 14.37M and accounting for 97.22% of total revenue.
KeyAI